Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research carried out by the Department of Physiology, Anatomy & Genetics represents advances in vascular development knowledge.

A new study published in Nature Communications highlights a major and previously unsuspected role for Bone Morphogenetic Proteins in the acquisition and maintenance of vein identity, through a detailed analysis of early vascular patterning in mice and zebrafish. BMPs are a group of growth factors originally discovered by their ability to induce the formation of bone and cartilage.

Lead Researcher Sarah De Val said "This work places BMP signalling at the top of a regulatory cascade that activates venous identity. It represents a fundamental advance in both our knowledge of vascular development and our understanding of the role of the BMP pathway. It also provides a wealth of novel targets for therapeutic manipulations of vascular growth, for example in heart disease and cancer." 

Read more (Department of Physiology, Anatomy & Genetics website)

 

 

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.